These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 34046141

  • 21. Systemic lupus erythematosus presenting as Stevens-Johnson syndrome and toxic epidermal necrolysis: a report of three cases.
    Lee HY, Tey HL, Pang SM, Thirumoorthy T.
    Lupus; 2011 May; 20(6):647-52. PubMed ID: 21148602
    [Abstract] [Full Text] [Related]

  • 22. Lupus-associated toxic epidermal necrolysis: a novel manifestation of lupus?
    Mandelcorn R, Shear NH.
    J Am Acad Dermatol; 2003 Apr; 48(4):525-9. PubMed ID: 12664014
    [Abstract] [Full Text] [Related]

  • 23. Toxic epidermal necrolysis with systemic lupus erythematosus: case report and review of the literature.
    Fan WY, Zhai QR, Ma QB, Ge HX.
    Ann Palliat Med; 2022 Jun; 11(6):2144-2151. PubMed ID: 34412491
    [Abstract] [Full Text] [Related]

  • 24. [Translated article] Indirect Immunofluorescence Findings in a Patient With Toxic Epidermal Necrolysis-Like Cutaneous Lupus Erythematosus.
    Morgado-Carrasco D, Mascaró JM.
    Actas Dermosifiliogr; 2022 Oct; 113(9):T905-T906. PubMed ID: 35934104
    [No Abstract] [Full Text] [Related]

  • 25. Rowell Syndrome in Nigeria: Systemic Lupus Erythematosus Presenting as Recurrent Erythema Multiforme in a Young Woman.
    Akintayo RO, Olarinoye GM, Akintayo FC, Ilesanmi ON.
    Acta Dermatovenerol Croat; 2019 Sep; 27(3):200-201. PubMed ID: 31542069
    [Abstract] [Full Text] [Related]

  • 26. Stevens-Johnson syndrome/toxic epidermal necrolysis-like cutaneous lupus erythematosus. A case series with long-term follow-up.
    Marti-Marti I, Morgado-Carrasco D, Carrera C, Alamon-Reig F, Serra-García L, Mascaró JM.
    J Eur Acad Dermatol Venereol; 2022 Feb; 36(2):e135-e139. PubMed ID: 34551165
    [No Abstract] [Full Text] [Related]

  • 27. Stevens-Johnson syndrome and toxic epidermal necrolysis in patients with lupus erythematosus: a descriptive study of 17 cases from a national registry and review of the literature.
    Ziemer M, Kardaun SH, Liss Y, Mockenhaupt M.
    Br J Dermatol; 2012 Mar; 166(3):575-600. PubMed ID: 22014091
    [Abstract] [Full Text] [Related]

  • 28. Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus successfully treated with a single dose of etanercept: report of three cases.
    Napolitano M, Giampetruzzi AR, Didona D, Papi M, Didona B.
    J Am Acad Dermatol; 2013 Dec; 69(6):e303-5. PubMed ID: 24238188
    [No Abstract] [Full Text] [Related]

  • 29. Chronic cutaneous lupus erythematosus presenting as atypical acneiform and comedonal plaque: case report and literature review.
    Vieira ML, Marques ERMC, Leda YLA, Noriega LF, Bet DL, Pereira GAAM.
    Lupus; 2018 Apr; 27(5):853-857. PubMed ID: 28857716
    [Abstract] [Full Text] [Related]

  • 30. Brief report: responses to rituximab suggest B cell-independent inflammation in cutaneous systemic lupus erythematosus.
    Vital EM, Wittmann M, Edward S, Md Yusof MY, MacIver H, Pease CT, Goodfield M, Emery P.
    Arthritis Rheumatol; 2015 Jun; 67(6):1586-91. PubMed ID: 25707733
    [Abstract] [Full Text] [Related]

  • 31. [Cutaneous lupus erythematosus and skin manifestations in systemic lupus erythematosus].
    Sticherling M.
    Z Rheumatol; 2013 Jun; 72(5):429-35. PubMed ID: 23743985
    [Abstract] [Full Text] [Related]

  • 32. Toxic epidermal necrolysis associated with pembrolizumab.
    Cai ZR, Lecours J, Adam JP, Marcil I, Blais N, Dallaire M, Belisle A, Mathieu A.
    J Oncol Pharm Pract; 2020 Jul; 26(5):1259-1265. PubMed ID: 31810421
    [Abstract] [Full Text] [Related]

  • 33. Lupus erythematosus and toxic epidermal necrolysis.
    Bielsa I, Herrero C, Font J, Mascaró JM.
    J Am Acad Dermatol; 1987 Jun; 16(6):1265-7. PubMed ID: 3597870
    [No Abstract] [Full Text] [Related]

  • 34. Toxic epidermal necrolysis after therapeutic plasma exchange in pediatric lupus patients and associated risk factors analysis.
    Lu J, Dong L, Zhang L, Zhang H, Wang L, Zhang J, Wan C.
    Lupus; 2021 Mar; 30(3):465-472. PubMed ID: 33413003
    [Abstract] [Full Text] [Related]

  • 35. [Systemic lupus erythematosus presenting as Stevens-Johnson syndrome].
    Bellakhal S, Ben Kaab B, Teyeb Z, Souissi A, Derbel F, Douggui MH.
    Pathol Biol (Paris); 2015 Sep; 63(4-5):222-3. PubMed ID: 26088436
    [Abstract] [Full Text] [Related]

  • 36. Blisters and Loss of Epidermis in Patients With Lupus Erythematosus: A Clinicopathological Study of 22 Patients.
    Merklen-Djafri C, Bessis D, Frances C, Poulalhon N, Debarbieux S, Cordel N, Lipsker D.
    Medicine (Baltimore); 2015 Nov; 94(46):e2102. PubMed ID: 26579826
    [Abstract] [Full Text] [Related]

  • 37. Stevens-Johnson syndrome and toxic epidermal necrolysis-like cutaneous presentation of chikungunya fever: A case series.
    Garg T, Sanke S, Ahmed R, Chander R, Basu S.
    Pediatr Dermatol; 2018 May; 35(3):392-396. PubMed ID: 29573443
    [Abstract] [Full Text] [Related]

  • 38. Cutaneous lupus erythematosus: issues in diagnosis and treatment.
    Walling HW, Sontheimer RD.
    Am J Clin Dermatol; 2009 May; 10(6):365-81. PubMed ID: 19824738
    [Abstract] [Full Text] [Related]

  • 39. Subacute cutaneous lupus erythematosus on the lines of Blaschko.
    Röckmann H, Feller G, Schadendorf D, Goerdt S.
    Eur J Dermatol; 2006 May; 16(3):302-6. PubMed ID: 16709500
    [Abstract] [Full Text] [Related]

  • 40. Subacute cutaneous lupus erythematosus versus systemic lupus erythematosus: diagnostic criteria and therapeutic implications.
    Chlebus E, Wolska H, Blaszczyk M, Jablonska S.
    J Am Acad Dermatol; 1998 Mar; 38(3):405-12. PubMed ID: 9520021
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.